These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 27225306)

  • 1. Vasculitis syndromes: Tocilizumab safe and effective for PMR.
    Shipman L
    Nat Rev Rheumatol; 2016 Jul; 12(7):374. PubMed ID: 27225306
    [No Abstract]   [Full Text] [Related]  

  • 2. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
    Macchioni P; Boiardi L; Catanoso M; Pulsatelli L; Pipitone N; Meliconi R; Salvarani C
    Semin Arthritis Rheum; 2013 Aug; 43(1):113-8. PubMed ID: 23433960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases.
    Izumi K; Kuda H; Ushikubo M; Kuwana M; Takeuchi T; Oshima H
    RMD Open; 2015; 1(1):e000162. PubMed ID: 26635968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective control of polymyalgia rheumatica with tocilizumab.
    Al Rashidi A; Hegazi MO; Mohammad SA; Varghese A
    J Clin Rheumatol; 2013 Oct; 19(7):400-1. PubMed ID: 24048113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
    Chatelain D; Duhaut P; Loire R; Bosshard S; Pellet H; Piette JC; Sevestre H; Ducroix JP
    Arthritis Rheum; 2008 Aug; 58(8):2565-73. PubMed ID: 18668584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
    Palard-Novello X; Querellou S; Gouillou M; Saraux A; Marhadour T; Garrigues F; Abgral R; Salaün PY; Devauchelle-Pensec V
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):773-9. PubMed ID: 26753600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with tocilizumab of pericarditis associated with rheumatoid arthritis.
    Yoshida S; Takeuchi T; Sawaki H; Imai T; Makino S; Hanafusa T
    Mod Rheumatol; 2014 Jul; 24(4):677-80. PubMed ID: 24517555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis.
    Yamashita H; Kubota K; Takahashi Y; Minaminoto R; Morooka M; Ito K; Kano T; Kaneko H; Takashima H; Mimoiri A
    Mod Rheumatol; 2012 Sep; 22(5):705-11. PubMed ID: 22205118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab.
    Berti A; Cavalli G; Campochiaro C; Guglielmi B; Baldissera E; Cappio S; Sabbadini MG; Doglioni C; Dagna L
    Semin Arthritis Rheum; 2015 Aug; 45(1):48-54. PubMed ID: 25841802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between rheumatic diseases and cancer: results from a clinical practice cohort study.
    Bellan M; Boggio E; Sola D; Gibbin A; Gualerzi A; Favretto S; Guaschino G; Bonometti R; Pedrazzoli R; Pirisi M; Sainaghi PP
    Intern Emerg Med; 2017 Aug; 12(5):621-627. PubMed ID: 28181122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association of polymyalgia rheumatica with myelodysplastic syndromes.
    Kohli M; Bennett RM
    J Rheumatol; 1994 Jul; 21(7):1357-9. PubMed ID: 7966085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica.
    Lavado-Pérez C; Martínez-Rodríguez I; Martínez-Amador N; Banzo I; Quirce R; Jiménez-Bonilla J; De Arcocha-Torres M; Bravo-Ferrer Z; Jiménez-Alonso M; López-Defilló JL; Blanco R; González-Gay MA; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):275-81. PubMed ID: 26159505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab improves systemic rheumatoid vasculitis with necrotizing crescentic glomerulonephritis.
    Iijima T; Suwabe T; Sumida K; Hayami N; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Sawa N; Takaichi K; Oohashi K; Fujii T; Ubara Y
    Mod Rheumatol; 2015 Jan; 25(1):138-42. PubMed ID: 24533557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymyalgia rheumatica: myalgic syndrome or occult vasculitis?].
    Hellmich B; Gross WL
    Internist (Berl); 2005 Nov; 46(11):1233-43. PubMed ID: 16151786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis.
    Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Mattey DL; Amoli MM; Thomson W; Ollier WE
    Clin Exp Rheumatol; 2002; 20(2):179-84. PubMed ID: 12051396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis.
    Cohen C; Mekinian A; Saidenberg-Kermanac'h N; Stirnemann J; Fenaux P; Gherardi R; Fain O
    Ann Rheum Dis; 2012 Apr; 71(4):628-9. PubMed ID: 22121135
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenic mechanisms of vessel damage in vasculitis syndromes.
    Sundy JS; Haynes BF
    Rheum Dis Clin North Am; 1995 Nov; 21(4):861-81. PubMed ID: 8592741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of interleukin 6 antagonist tocilizumab in a patient with refractory cutaneous lupus and urticarial vasculitis.
    Makol A; Gibson LE; Michet CJ
    J Clin Rheumatol; 2012 Mar; 18(2):92-5. PubMed ID: 22334272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxic assessment of Polygoni Multiflori Radix extract and toxicokinetic study of stilbene glucoside and anthraquinones in rats.
    Ma J; Zheng L; He YS; Li HJ
    J Ethnopharmacol; 2015 Mar; 162():61-8. PubMed ID: 25557036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.